ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy

F. Lin, M.C. de Gooijer, E.M. Roig, L.C.M. Buil, S.M. Christner, J.H. Beumer, T. Wurdinger, J.H. Beijnen, O. van Tellingen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2703-2713
JournalClinical Cancer Research
Volume20
Issue number10
DOIs
Publication statusPublished - 2014

Cite this

Lin, F., de Gooijer, M. C., Roig, E. M., Buil, L. C. M., Christner, S. M., Beumer, J. H., ... van Tellingen, O. (2014). ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy. Clinical Cancer Research, 20(10), 2703-2713. https://doi.org/10.1158/1078-0432.CCR-14-0084